Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert Oriol

Showing results (241-250 of 250) with videos related to

Pageof 25
Sort By:
You have reached the last page of results.This site can display upto 250 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2023
Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal GammopathiesLeire Burgos, Luis-Esteban Tamariz-Amador, Noemi Puig, et al.
Blood|July 22, 2020
Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard- and high-risk myelomaIbai Goicoechea, Noemi Puig, Maria-Teresa Cedena, et al.
Blood Cancer Journal|April 20, 2022
A simple score to predict early severe infections in patients with newly diagnosed multiple myelomaCristina Encinas, José-Ángel Hernandez-Rivas, Albert Oriol, et al.
The New England Journal of Medicine|May 29, 2026
Teclistamab in Multiple Myeloma with One to Three Previous Lines of TherapyCyrille Touzeau, Roberto Mina, Hang Quach, et al.
American Journal of Human Genetics|August 25, 2022
A genome sequencing system for universal newborn screening, diagnosis, and precision medicine for severe genetic diseasesStephen F Kingsmore, Laurie D Smith, Chris M Kunard, et al.
Blood|January 29, 2026
Immune biomarkers of increased infection risk in multiple myelomaAintzane Zabaleta, Luis-Esteban Tamariz-Amador, Ioannis V Kostopoulos, et al.
The New England Journal of Medicine|June 15, 2026
Talquetamab-Daratumumab in Relapsed or Refractory MyelomaRoberto Mina, Meral Beksac, Paula Rodríguez-Otero, et al.
Science Translational Medicine|April 26, 2019
Diagnosis of genetic diseases in seriously ill children by rapid whole-genome sequencing and automated phenotyping and interpretationMichelle M Clark, Amber Hildreth, Sergey Batalov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2022
Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple MyelomaRosalinda Termini, David Žihala, Evangelos Terpos, et al.
Nature Communications|July 26, 2022
An automated 13.5 hour system for scalable diagnosis and acute management guidance for genetic diseasesMallory J Owen, Sebastien Lefebvre, Christian Hansen, et al.
Pageof 25

Showing results (241-250 of 250) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 250 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2023
Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal GammopathiesLeire Burgos, Luis-Esteban Tamariz-Amador, Noemi Puig, et al.
Blood|July 22, 2020
Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard- and high-risk myelomaIbai Goicoechea, Noemi Puig, Maria-Teresa Cedena, et al.
Blood Cancer Journal|April 20, 2022
A simple score to predict early severe infections in patients with newly diagnosed multiple myelomaCristina Encinas, José-Ángel Hernandez-Rivas, Albert Oriol, et al.
The New England Journal of Medicine|May 29, 2026
Teclistamab in Multiple Myeloma with One to Three Previous Lines of TherapyCyrille Touzeau, Roberto Mina, Hang Quach, et al.
American Journal of Human Genetics|August 25, 2022
A genome sequencing system for universal newborn screening, diagnosis, and precision medicine for severe genetic diseasesStephen F Kingsmore, Laurie D Smith, Chris M Kunard, et al.
Blood|January 29, 2026
Immune biomarkers of increased infection risk in multiple myelomaAintzane Zabaleta, Luis-Esteban Tamariz-Amador, Ioannis V Kostopoulos, et al.
The New England Journal of Medicine|June 15, 2026
Talquetamab-Daratumumab in Relapsed or Refractory MyelomaRoberto Mina, Meral Beksac, Paula Rodríguez-Otero, et al.
Science Translational Medicine|April 26, 2019
Diagnosis of genetic diseases in seriously ill children by rapid whole-genome sequencing and automated phenotyping and interpretationMichelle M Clark, Amber Hildreth, Sergey Batalov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2022
Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple MyelomaRosalinda Termini, David Žihala, Evangelos Terpos, et al.
Nature Communications|July 26, 2022
An automated 13.5 hour system for scalable diagnosis and acute management guidance for genetic diseasesMallory J Owen, Sebastien Lefebvre, Christian Hansen, et al.
Pageof 25